BeiGene Ltd. ADR [ONC] stock prices are up 1.82% to $267.39 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ONC shares have gain 6.12% over the last week, with a monthly amount drifted -3.95%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
BeiGene Ltd. ADR [NASDAQ: ONC] stock has seen the most recent analyst activity on March 03, 2025, when BofA Securities upgraded its rating to a Buy and also boosted its price target to $320 from $207. On September 18, 2024, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $288 on the stock. Macquarie initiated its recommendation with a Outperform and recommended $259 as its price target on September 12, 2023. Jefferies started tracking with a Buy rating for this stock on August 17, 2023, and assigned it a price target of $287. In a note dated July 17, 2023, Citigroup initiated an Buy rating and provided a target price of $275 on this stock.
The stock price of BeiGene Ltd. ADR [ONC] has been fluctuating between $126.97 and $287.88 over the past year. Currently, Wall Street analysts expect the stock to reach $303.5 within the next 12 months. BeiGene Ltd. ADR [NASDAQ: ONC] shares were valued at $267.39 at the most recent close of the market. An investor can expect a potential return of 13.5% based on the average ONC price forecast.
Analyzing the ONC fundamentals
The BeiGene Ltd. ADR [NASDAQ:ONC] reported sales of 3.81B for trailing twelve months, representing a surge of 77.78%. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.14%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.19 and Total Capital is -0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 263.98 points at the first support level, and at 260.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 272.40, and for the 2nd resistance point, it is at 277.41.
Ratios To Look Out For
It’s worth pointing out that BeiGene Ltd. ADR [NASDAQ:ONC]’s Current Ratio is 1.80. Further, the Quick Ratio stands at 1.58, while the Cash Ratio is 1.19. Considering the valuation of this stock, the price to sales ratio is 6.93, the price to book ratio is 8.56.
Transactions by insiders
Recent insider trading involved Wang Xiaodong, Chair, Scientific Advisory Brd, that happened on Mar 18 ’25 when 41760.0 shares were sold. Chief Executive Officer, OYLER JOHN completed a deal on Mar 10 ’25 to sell 41210.0 shares. Meanwhile, Officer JOHN OYLER bought 41210.0 shares on Mar 10 ’25.
